LLBO Lifeline Biotech Inc (CE)

Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today announced that management is preparing for a filing with the FDA for the Company�s First Warning System�, a capable process designed to assist in the early detection of breast cancer.

Jim Holmes, CEO of Lifeline, said that its �subsidiary, First Warning Systems, Inc., is focused on preparing a preliminary filing with the FDA. The FDA�s response to this initial filing could take several months to receive. We expect the FDA�s response to give us guidance for the subsequent filing required in order to obtain marketing clearance for this proprietary process.�

Lifeline Biotechnologies has in the past year filed for a patent on the recent technological advancements of the First Warning System�, which has achieved the robust capability of identifying and classifying tissue abnormalities of the breast with sensitivities (ability to identify) of 95% to 100% and specificities (verify) of 87% to 90%. Currently, it is a well known fact that mammograms are missing an estimated 20% to 30% of the breast cancers.

Holmes noted that �Brass Bulls, an investor relations firm previously assisting the Company, will no longer be used as their consulting agreement has expired. The Company�s website has been updated and our direct phone number has been included thereon.�

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing, successful development of the Company�s product and regulatory and shareholder approval for anticipated actions.

Lifeline Biotech (CE) (USOTC:LLBO)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024

Lifeline Biotech (CE) (USOTC:LLBO)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024